GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (OTCPK:TBGNF) » Definitions » Common Stock

Oxurion NV (Oxurion NV) Common Stock : $79.60 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Oxurion NV Common Stock?

Oxurion NV's quarterly common stock increased from Dec. 2022 ($69.33 Mil) to Jun. 2023 ($76.16 Mil) and increased from Jun. 2023 ($76.16 Mil) to Dec. 2023 ($79.60 Mil).

Oxurion NV's annual common stock increased from Dec. 2021 ($52.01 Mil) to Dec. 2022 ($69.33 Mil) and increased from Dec. 2022 ($69.33 Mil) to Dec. 2023 ($79.60 Mil).

Oxurion NV Common Stock Historical Data

The historical data trend for Oxurion NV's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Common Stock Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.83 54.64 52.01 69.33 79.60

Oxurion NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.01 62.41 69.33 76.16 79.60

Oxurion NV Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Oxurion NV (Oxurion NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (OTCPK:TBGNF) » Definitions » Common Stock
Comparable Companies
XBRU:ACCB XBRU:INCLU XBRU:ZEN XBRU:MCC XBRU:BAS OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX ALNY OCSE:GMAB BGNE BMRN INCY
Traded in Other Exchanges
TG4:Germany OXUR:Belgium
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Website
https://www.oxurion.com
Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.